Data Curation Workflows That Enhance RWE Reliability and Auditability In the evolving landscape of regulatory science, the quality and integrity of real-world data (RWD) have become paramount for the success of health interventions and regulatory submissions. Accurate data curation workflows improve the reliability and auditability of RWD, making it essential for pharmaceutical and medtech professionals to understand how to manage these processes effectively. This tutorial outlines a comprehensive step-by-step guide designed to help regulatory, biostatistics, Health Economics and Outcomes Research (HEOR), and data standards professionals enhance their data curation practices in accordance with U.S. FDA regulations. Understanding Real-World Data Quality,…

Handling Misclassification and Measurement Error in Claims and EHR Data Introduction to Misclassification and Measurement Error In the domain of real-world evidence (RWE), the integrity and quality of real-world data (RWD) are paramount. Misclassification and measurement errors can significantly compromise the validity of research outcomes derived from claims data and electronic health records (EHR). These inaccuracies not only pose challenges for regulatory submissions but can also lead to biased conclusions in health economics and outcomes research (HEOR). This article aims to provide a comprehensive, step-by-step tutorial on handling misclassification and measurement error in claims and EHR data, specifically focusing on…

Detecting and Mitigating Selection Bias in Observational RWE Studies Detecting and Mitigating Selection Bias in Observational RWE Studies As real-world evidence (RWE) gains acceptance in regulatory decision-making, understanding the intricacies of data quality, integrity, and bias management becomes paramount. This tutorial aims to provide a comprehensive overview of detecting and mitigating selection bias in observational RWE studies, focusing on regulatory expectations and best practices in the US, UK, and EU. The goal is to equip regulatory professionals, biostatisticians, and data managers with the necessary tools to ensure the reliability of RWE in supporting healthcare decisions. 1. Understanding Selection Bias in…

Frameworks for assessing RWD fitness for purpose in RWE programs Frameworks for Assessing RWD Fitness for Purpose in RWE Programs Real-world data (RWD) has become paramount in informing healthcare decisions and enhancing the understanding of treatment effectiveness and safety. However, ensuring the quality, integrity, and management of bias in RWD is crucial for its effective utilization. This comprehensive tutorial provides a step-by-step guide for assessing the fitness for purpose of RWD within real-world evidence (RWE) programs, with a focus on regulatory compliance in the United States. The tutorial also references methodologies applicable in the UK and EU when relevant. 1….

Quality and Integrity Pillars for Regulatory Grade Real World Data Sets As the integration of real-world data (RWD) into clinical research and regulatory decision-making continues to expand, the importance of maintaining data quality and integrity cannot be overstated. Regulatory bodies like the U.S. Food and Drug Administration (FDA) have emphasized the need for robust quality frameworks when utilizing RWD for submissions and regulatory decisions. This comprehensive tutorial aims to provide a step-by-step guide for professionals in the pharmaceutical and medtech industries on how to ensure the quality and integrity of real-world data sets, focusing on key aspects such as bias…

Balancing Data Richness with Privacy and De-identification Constraints In the realm of clinical research, particularly concerning real-world data (RWD), there is an ongoing interplay between the richness of data and the imperative to maintain privacy. As healthcare data becomes more extensive and varied, the challenge arises to ensure data quality and integrity while effectively managing potential biases. This tutorial will guide you through the complexities of real-world data quality integrity bias management, focusing on the U.S. FDA regulations and the best practices to foster compliance. We will delve into the nuances of RWD fitness for purpose, selection bias, misclassification, data…

Case Examples of RWE Rejected Due to RWD Quality Concerns In recent years, real-world evidence (RWE) has gained prominence in regulatory decision-making processes, steering the pharmaceutical and medical device industries toward evidence-based practices. However, the use of real-world data (RWD) necessitates an unwavering commitment to data quality, integrity, and bias management. This article presents a comprehensive tutorial on RWE, emphasizing case examples where RWD submissions were rejected due to quality concerns, thereby providing regulatory, biostatistics, health economics and outcomes research (HEOR), and data standards professionals with critical insights into fitness for purpose in RWD. Understanding Real-World Evidence and Real-World Data…

Using Sensitivity Analyses to Address Unmeasured Confounding and Bias In the rapidly evolving landscape of pharmaceuticals and medical technology, the reliance on real-world data (RWD) is becoming increasingly prominent. As regulatory agencies like the US FDA embrace these data sources, it is essential for professionals in the domain to grasp the nuances of real world data quality integrity bias management. One fundamental aspect of ensuring the robustness of conclusions drawn from RWD is the implementation of sensitivity analyses. This tutorial provides a comprehensive step-by-step approach to integrating sensitivity analyses in order to address unmeasured confounding and bias in RWD. Understanding…

Governance models for RWD quality review boards and data stewards Governance Models for RWD Quality Review Boards and Data Stewards In the evolving landscape of healthcare and life sciences, the importance of real-world data (RWD) has become increasingly crucial for regulatory submissions and decision-making processes. Governance models for RWD quality review boards and data stewards play a fundamental role in ensuring the integrity and quality of real-world data quality integrity bias management. This comprehensive tutorial will guide you through the various aspects of establishing effective governance models for RWD, focusing on RWD fitness for purpose and the management of selection…

Provenance, Lineage and Traceability Controls for Complex RWD Pipelines Real-world data (RWD) plays a pivotal role in the regulatory landscape by providing insights that can influence clinical and regulatory decisions. However, harnessing RWD presents unique challenges related to quality, integrity, and bias management. This article serves as a comprehensive guide to understanding provenance, lineage, and traceability controls within complex RWD pipelines, ensuring they meet the rigorous standards expected by FDA guidance. Understanding Real-World Data and Its Importance Real-world data refers to information collected outside of traditional clinical trials, derived from various sources including electronic health records (EHRs), patient registries, claims…